Emerald Resources NL
Get $10 bonus on your first $100 deposit for EMR.AX
Get $10 bonus on your first $100 deposit for EMR.AX
Emerald Resources NL (EMR.AX) Stock Competitors & Peer Comparison
See (EMR.AX) competitors and their performances in Stock Market.
Peer Comparison Table: Gold Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| EMR.AX | A$5.66 | -2.75% | 3.7B | 37.73 | A$0.15 | N/A |
| NEM.AX | A$159.33 | +0.57% | 173.3B | 17.24 | A$9.24 | +0.95% |
| NST.AX | A$21.91 | -0.86% | 31.3B | 18.73 | A$1.17 | +2.51% |
| EVN.AX | A$13.02 | -4.62% | 26.4B | 19.73 | A$0.66 | +2.53% |
| NCM.AX | A$23.35 | -1.27% | 20.9B | 17.56 | A$1.33 | +10.00% |
| AGG.AX | A$6.51 | -3.27% | 13.9B | 50.08 | A$0.13 | +1.95% |
| DPM.AX | A$52.57 | +2.62% | 11.7B | 18.13 | A$2.90 | +0.34% |
| GGP.AX | A$12.85 | -1.38% | 8.6B | 7.26 | A$1.77 | N/A |
| PRU.AX | A$5.28 | -2.76% | 7.1B | 13.89 | A$0.38 | +1.89% |
| RMS.AX | A$3.68 | -5.15% | 7B | 14.72 | A$0.25 | +2.17% |
Stock Comparison
EMR.AX vs NEM.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, NEM.AX has a market cap of 173.3B. Regarding current trading prices, EMR.AX is priced at A$5.66, while NEM.AX trades at A$159.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas NEM.AX's P/E ratio is 17.24. In terms of profitability, EMR.AX's ROE is +0.15%, compared to NEM.AX's ROE of +0.22%. Regarding short-term risk, EMR.AX is more volatile compared to NEM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check NEM.AX's competition here
EMR.AX vs NST.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, NST.AX has a market cap of 31.3B. Regarding current trading prices, EMR.AX is priced at A$5.66, while NST.AX trades at A$21.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas NST.AX's P/E ratio is 18.73. In terms of profitability, EMR.AX's ROE is +0.15%, compared to NST.AX's ROE of +0.10%. Regarding short-term risk, EMR.AX is more volatile compared to NST.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check NST.AX's competition here
EMR.AX vs EVN.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, EVN.AX has a market cap of 26.4B. Regarding current trading prices, EMR.AX is priced at A$5.66, while EVN.AX trades at A$13.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas EVN.AX's P/E ratio is 19.73. In terms of profitability, EMR.AX's ROE is +0.15%, compared to EVN.AX's ROE of +0.25%. Regarding short-term risk, EMR.AX is less volatile compared to EVN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check EVN.AX's competition here
EMR.AX vs NCM.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, NCM.AX has a market cap of 20.9B. Regarding current trading prices, EMR.AX is priced at A$5.66, while NCM.AX trades at A$23.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas NCM.AX's P/E ratio is 17.56. In terms of profitability, EMR.AX's ROE is +0.15%, compared to NCM.AX's ROE of +0.07%. Regarding short-term risk, EMR.AX is more volatile compared to NCM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check NCM.AX's competition here
EMR.AX vs AGG.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, AGG.AX has a market cap of 13.9B. Regarding current trading prices, EMR.AX is priced at A$5.66, while AGG.AX trades at A$6.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas AGG.AX's P/E ratio is 50.08. In terms of profitability, EMR.AX's ROE is +0.15%, compared to AGG.AX's ROE of +0.32%. Regarding short-term risk, EMR.AX is more volatile compared to AGG.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check AGG.AX's competition here
EMR.AX vs DPM.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, DPM.AX has a market cap of 11.7B. Regarding current trading prices, EMR.AX is priced at A$5.66, while DPM.AX trades at A$52.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas DPM.AX's P/E ratio is 18.13. In terms of profitability, EMR.AX's ROE is +0.15%, compared to DPM.AX's ROE of +0.20%. Regarding short-term risk, EMR.AX is more volatile compared to DPM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check DPM.AX's competition here
EMR.AX vs GGP.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, GGP.AX has a market cap of 8.6B. Regarding current trading prices, EMR.AX is priced at A$5.66, while GGP.AX trades at A$12.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas GGP.AX's P/E ratio is 7.26. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GGP.AX's ROE of +0.42%. Regarding short-term risk, EMR.AX is less volatile compared to GGP.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check GGP.AX's competition here
EMR.AX vs PRU.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, PRU.AX has a market cap of 7.1B. Regarding current trading prices, EMR.AX is priced at A$5.66, while PRU.AX trades at A$5.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas PRU.AX's P/E ratio is 13.89. In terms of profitability, EMR.AX's ROE is +0.15%, compared to PRU.AX's ROE of +0.12%. Regarding short-term risk, EMR.AX is more volatile compared to PRU.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check PRU.AX's competition here
EMR.AX vs RMS.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, RMS.AX has a market cap of 7B. Regarding current trading prices, EMR.AX is priced at A$5.66, while RMS.AX trades at A$3.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas RMS.AX's P/E ratio is 14.72. In terms of profitability, EMR.AX's ROE is +0.15%, compared to RMS.AX's ROE of +0.10%. Regarding short-term risk, EMR.AX is less volatile compared to RMS.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check RMS.AX's competition here
EMR.AX vs GMD.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, GMD.AX has a market cap of 6.7B. Regarding current trading prices, EMR.AX is priced at A$5.66, while GMD.AX trades at A$5.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas GMD.AX's P/E ratio is 16.77. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GMD.AX's ROE of +0.29%. Regarding short-term risk, EMR.AX is less volatile compared to GMD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check GMD.AX's competition here
EMR.AX vs DEG.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, DEG.AX has a market cap of 5.9B. Regarding current trading prices, EMR.AX is priced at A$5.66, while DEG.AX trades at A$2.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas DEG.AX's P/E ratio is -246.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to DEG.AX's ROE of -0.02%. Regarding short-term risk, EMR.AX is less volatile compared to DEG.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check DEG.AX's competition here
EMR.AX vs WGX.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, WGX.AX has a market cap of 5.7B. Regarding current trading prices, EMR.AX is priced at A$5.66, while WGX.AX trades at A$6.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas WGX.AX's P/E ratio is 22.26. In terms of profitability, EMR.AX's ROE is +0.15%, compared to WGX.AX's ROE of +0.12%. Regarding short-term risk, EMR.AX is less volatile compared to WGX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check WGX.AX's competition here
EMR.AX vs RRL.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, RRL.AX has a market cap of 5.1B. Regarding current trading prices, EMR.AX is priced at A$5.66, while RRL.AX trades at A$6.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas RRL.AX's P/E ratio is 10.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to RRL.AX's ROE of +0.28%. Regarding short-term risk, EMR.AX is less volatile compared to RRL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check RRL.AX's competition here
EMR.AX vs CMM.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, CMM.AX has a market cap of 5B. Regarding current trading prices, EMR.AX is priced at A$5.66, while CMM.AX trades at A$10.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas CMM.AX's P/E ratio is 20.26. In terms of profitability, EMR.AX's ROE is +0.15%, compared to CMM.AX's ROE of +0.23%. Regarding short-term risk, EMR.AX is less volatile compared to CMM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check CMM.AX's competition here
EMR.AX vs VAU.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, VAU.AX has a market cap of 4.3B. Regarding current trading prices, EMR.AX is priced at A$5.66, while VAU.AX trades at A$4.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas VAU.AX's P/E ratio is 51.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to VAU.AX's ROE of +0.04%. Regarding short-term risk, EMR.AX is less volatile compared to VAU.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check VAU.AX's competition here
EMR.AX vs GOR.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, GOR.AX has a market cap of 3.8B. Regarding current trading prices, EMR.AX is priced at A$5.66, while GOR.AX trades at A$3.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas GOR.AX's P/E ratio is 18.32. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GOR.AX's ROE of +0.15%. Regarding short-term risk, EMR.AX is more volatile compared to GOR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check GOR.AX's competition here
EMR.AX vs WAF.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, WAF.AX has a market cap of 3.7B. Regarding current trading prices, EMR.AX is priced at A$5.66, while WAF.AX trades at A$3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas WAF.AX's P/E ratio is 7.90. In terms of profitability, EMR.AX's ROE is +0.15%, compared to WAF.AX's ROE of +0.42%. Regarding short-term risk, EMR.AX is more volatile compared to WAF.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check WAF.AX's competition here
EMR.AX vs SSR.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, SSR.AX has a market cap of 3.2B. Regarding current trading prices, EMR.AX is priced at A$5.66, while SSR.AX trades at A$15.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas SSR.AX's P/E ratio is -7.30. In terms of profitability, EMR.AX's ROE is +0.15%, compared to SSR.AX's ROE of +0.02%. Regarding short-term risk, EMR.AX is more volatile compared to SSR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check SSR.AX's competition here
EMR.AX vs RSG.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, RSG.AX has a market cap of 3B. Regarding current trading prices, EMR.AX is priced at A$5.66, while RSG.AX trades at A$1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas RSG.AX's P/E ratio is 15.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to RSG.AX's ROE of +0.17%. Regarding short-term risk, EMR.AX is less volatile compared to RSG.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check RSG.AX's competition here
EMR.AX vs SPR.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, SPR.AX has a market cap of 2.8B. Regarding current trading prices, EMR.AX is priced at A$5.66, while SPR.AX trades at A$2.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas SPR.AX's P/E ratio is -35.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to SPR.AX's ROE of -0.41%. Regarding short-term risk, EMR.AX is more volatile compared to SPR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check SPR.AX's competition here
EMR.AX vs RED.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, RED.AX has a market cap of 2.3B. Regarding current trading prices, EMR.AX is priced at A$5.66, while RED.AX trades at A$0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas RED.AX's P/E ratio is 17.10. In terms of profitability, EMR.AX's ROE is +0.15%, compared to RED.AX's ROE of -0.01%. Regarding short-term risk, EMR.AX is more volatile compared to RED.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check RED.AX's competition here
EMR.AX vs BGL.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, BGL.AX has a market cap of 2.3B. Regarding current trading prices, EMR.AX is priced at A$5.66, while BGL.AX trades at A$1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas BGL.AX's P/E ratio is -38.25. In terms of profitability, EMR.AX's ROE is +0.15%, compared to BGL.AX's ROE of -0.07%. Regarding short-term risk, EMR.AX is less volatile compared to BGL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check BGL.AX's competition here
EMR.AX vs PDI.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, PDI.AX has a market cap of 2.2B. Regarding current trading prices, EMR.AX is priced at A$5.66, while PDI.AX trades at A$0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas PDI.AX's P/E ratio is -83.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to PDI.AX's ROE of -0.08%. Regarding short-term risk, EMR.AX is more volatile compared to PDI.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check PDI.AX's competition here
EMR.AX vs OBM.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, OBM.AX has a market cap of 2.2B. Regarding current trading prices, EMR.AX is priced at A$5.66, while OBM.AX trades at A$1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas OBM.AX's P/E ratio is 9.33. In terms of profitability, EMR.AX's ROE is +0.15%, compared to OBM.AX's ROE of +0.68%. Regarding short-term risk, EMR.AX is less volatile compared to OBM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check OBM.AX's competition here
EMR.AX vs ALK.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, ALK.AX has a market cap of 2B. Regarding current trading prices, EMR.AX is priced at A$5.66, while ALK.AX trades at A$1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas ALK.AX's P/E ratio is 16.56. In terms of profitability, EMR.AX's ROE is +0.15%, compared to ALK.AX's ROE of +0.10%. Regarding short-term risk, EMR.AX is less volatile compared to ALK.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check ALK.AX's competition here
EMR.AX vs CYL.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, CYL.AX has a market cap of 1.6B. Regarding current trading prices, EMR.AX is priced at A$5.66, while CYL.AX trades at A$6.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas CYL.AX's P/E ratio is 14.93. In terms of profitability, EMR.AX's ROE is +0.15%, compared to CYL.AX's ROE of +0.23%. Regarding short-term risk, EMR.AX is less volatile compared to CYL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check CYL.AX's competition here
EMR.AX vs SLR.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, SLR.AX has a market cap of 1.5B. Regarding current trading prices, EMR.AX is priced at A$5.66, while SLR.AX trades at A$1.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas SLR.AX's P/E ratio is 15.65. In terms of profitability, EMR.AX's ROE is +0.15%, compared to SLR.AX's ROE of +0.03%. Regarding short-term risk, EMR.AX is more volatile compared to SLR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check SLR.AX's competition here
EMR.AX vs DTR.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, DTR.AX has a market cap of 1.5B. Regarding current trading prices, EMR.AX is priced at A$5.66, while DTR.AX trades at A$0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas DTR.AX's P/E ratio is -10.12. In terms of profitability, EMR.AX's ROE is +0.15%, compared to DTR.AX's ROE of -0.64%. Regarding short-term risk, EMR.AX is less volatile compared to DTR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check DTR.AX's competition here
EMR.AX vs ORE.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, ORE.AX has a market cap of 1.4B. Regarding current trading prices, EMR.AX is priced at A$5.66, while ORE.AX trades at A$2.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas ORE.AX's P/E ratio is 14.81. In terms of profitability, EMR.AX's ROE is +0.15%, compared to ORE.AX's ROE of +0.21%. Regarding short-term risk, EMR.AX is less volatile compared to ORE.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check ORE.AX's competition here
EMR.AX vs PNR.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, PNR.AX has a market cap of 1.4B. Regarding current trading prices, EMR.AX is priced at A$5.66, while PNR.AX trades at A$3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas PNR.AX's P/E ratio is 12.96. In terms of profitability, EMR.AX's ROE is +0.15%, compared to PNR.AX's ROE of +0.20%. Regarding short-term risk, EMR.AX is less volatile compared to PNR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check PNR.AX's competition here
EMR.AX vs KCN.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, KCN.AX has a market cap of 1.2B. Regarding current trading prices, EMR.AX is priced at A$5.66, while KCN.AX trades at A$4.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas KCN.AX's P/E ratio is 9.93. In terms of profitability, EMR.AX's ROE is +0.15%, compared to KCN.AX's ROE of +0.31%. Regarding short-term risk, EMR.AX is less volatile compared to KCN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check KCN.AX's competition here
EMR.AX vs TIE.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, TIE.AX has a market cap of 776.2M. Regarding current trading prices, EMR.AX is priced at A$5.66, while TIE.AX trades at A$0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas TIE.AX's P/E ratio is -9.67. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TIE.AX's ROE of +0.02%. Regarding short-term risk, EMR.AX is more volatile compared to TIE.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check TIE.AX's competition here
EMR.AX vs SBM.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, SBM.AX has a market cap of 768.2M. Regarding current trading prices, EMR.AX is priced at A$5.66, while SBM.AX trades at A$0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas SBM.AX's P/E ratio is -10.58. In terms of profitability, EMR.AX's ROE is +0.15%, compared to SBM.AX's ROE of -0.11%. Regarding short-term risk, EMR.AX is less volatile compared to SBM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check SBM.AX's competition here
EMR.AX vs SXG.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, SXG.AX has a market cap of 764.6M. Regarding current trading prices, EMR.AX is priced at A$5.66, while SXG.AX trades at A$3.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas SXG.AX's P/E ratio is -86.25. In terms of profitability, EMR.AX's ROE is +0.15%, compared to SXG.AX's ROE of -0.23%. Regarding short-term risk, EMR.AX is less volatile compared to SXG.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check SXG.AX's competition here
EMR.AX vs BC8.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, BC8.AX has a market cap of 746.5M. Regarding current trading prices, EMR.AX is priced at A$5.66, while BC8.AX trades at A$1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas BC8.AX's P/E ratio is 51.25. In terms of profitability, EMR.AX's ROE is +0.15%, compared to BC8.AX's ROE of +0.06%. Regarding short-term risk, EMR.AX is less volatile compared to BC8.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check BC8.AX's competition here
EMR.AX vs FML.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, FML.AX has a market cap of 699.2M. Regarding current trading prices, EMR.AX is priced at A$5.66, while FML.AX trades at A$2.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas FML.AX's P/E ratio is 10.17. In terms of profitability, EMR.AX's ROE is +0.15%, compared to FML.AX's ROE of +0.73%. Regarding short-term risk, EMR.AX is less volatile compared to FML.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check FML.AX's competition here
EMR.AX vs TCG.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, TCG.AX has a market cap of 658M. Regarding current trading prices, EMR.AX is priced at A$5.66, while TCG.AX trades at A$0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas TCG.AX's P/E ratio is -31.25. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TCG.AX's ROE of -0.07%. Regarding short-term risk, EMR.AX is less volatile compared to TCG.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check TCG.AX's competition here
EMR.AX vs WIA.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, WIA.AX has a market cap of 635.1M. Regarding current trading prices, EMR.AX is priced at A$5.66, while WIA.AX trades at A$0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas WIA.AX's P/E ratio is -43.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to WIA.AX's ROE of -0.18%. Regarding short-term risk, EMR.AX is less volatile compared to WIA.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check WIA.AX's competition here
EMR.AX vs WC8.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, WC8.AX has a market cap of 529.1M. Regarding current trading prices, EMR.AX is priced at A$5.66, while WC8.AX trades at A$0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas WC8.AX's P/E ratio is -39.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to WC8.AX's ROE of -0.02%. Regarding short-term risk, EMR.AX is more volatile compared to WC8.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check WC8.AX's competition here
EMR.AX vs MEK.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, MEK.AX has a market cap of 500.8M. Regarding current trading prices, EMR.AX is priced at A$5.66, while MEK.AX trades at A$0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas MEK.AX's P/E ratio is 17.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to MEK.AX's ROE of +0.17%. Regarding short-term risk, EMR.AX is less volatile compared to MEK.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check MEK.AX's competition here
EMR.AX vs AUC.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, AUC.AX has a market cap of 388.8M. Regarding current trading prices, EMR.AX is priced at A$5.66, while AUC.AX trades at A$0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas AUC.AX's P/E ratio is -30.17. In terms of profitability, EMR.AX's ROE is +0.15%, compared to AUC.AX's ROE of -0.09%. Regarding short-term risk, EMR.AX is more volatile compared to AUC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check AUC.AX's competition here
EMR.AX vs BCN.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, BCN.AX has a market cap of 378.6M. Regarding current trading prices, EMR.AX is priced at A$5.66, while BCN.AX trades at A$3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas BCN.AX's P/E ratio is 42.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to BCN.AX's ROE of +0.11%. Regarding short-term risk, EMR.AX is less volatile compared to BCN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check BCN.AX's competition here
EMR.AX vs DCN.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, DCN.AX has a market cap of 346.8M. Regarding current trading prices, EMR.AX is priced at A$5.66, while DCN.AX trades at A$0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas DCN.AX's P/E ratio is -5.70. In terms of profitability, EMR.AX's ROE is +0.15%, compared to DCN.AX's ROE of -0.74%. Regarding short-term risk, EMR.AX is more volatile compared to DCN.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check DCN.AX's competition here
EMR.AX vs RXL.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, RXL.AX has a market cap of 331.5M. Regarding current trading prices, EMR.AX is priced at A$5.66, while RXL.AX trades at A$0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas RXL.AX's P/E ratio is -11.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to RXL.AX's ROE of -0.16%. Regarding short-term risk, EMR.AX is less volatile compared to RXL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check RXL.AX's competition here
EMR.AX vs TBR.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, TBR.AX has a market cap of 308M. Regarding current trading prices, EMR.AX is priced at A$5.66, while TBR.AX trades at A$5.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas TBR.AX's P/E ratio is 7.07. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TBR.AX's ROE of +0.17%. Regarding short-term risk, EMR.AX is less volatile compared to TBR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check TBR.AX's competition here
EMR.AX vs WWI.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, WWI.AX has a market cap of 282.5M. Regarding current trading prices, EMR.AX is priced at A$5.66, while WWI.AX trades at A$0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas WWI.AX's P/E ratio is -6.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to WWI.AX's ROE of -0.10%. Regarding short-term risk, EMR.AX is less volatile compared to WWI.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check WWI.AX's competition here
EMR.AX vs ASL.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, ASL.AX has a market cap of 276.7M. Regarding current trading prices, EMR.AX is priced at A$5.66, while ASL.AX trades at A$1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas ASL.AX's P/E ratio is -16.37. In terms of profitability, EMR.AX's ROE is +0.15%, compared to ASL.AX's ROE of -0.37%. Regarding short-term risk, EMR.AX is less volatile compared to ASL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check ASL.AX's competition here
EMR.AX vs ORR.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, ORR.AX has a market cap of 267.5M. Regarding current trading prices, EMR.AX is priced at A$5.66, while ORR.AX trades at A$0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas ORR.AX's P/E ratio is -5.65. In terms of profitability, EMR.AX's ROE is +0.15%, compared to ORR.AX's ROE of -0.49%. Regarding short-term risk, EMR.AX is more volatile compared to ORR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check ORR.AX's competition here
EMR.AX vs AAR.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, AAR.AX has a market cap of 257.6M. Regarding current trading prices, EMR.AX is priced at A$5.66, while AAR.AX trades at A$0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas AAR.AX's P/E ratio is -18.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to AAR.AX's ROE of -0.03%. Regarding short-term risk, EMR.AX is less volatile compared to AAR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check AAR.AX's competition here
EMR.AX vs ERM.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, ERM.AX has a market cap of 251.7M. Regarding current trading prices, EMR.AX is priced at A$5.66, while ERM.AX trades at A$0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas ERM.AX's P/E ratio is -38.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to ERM.AX's ROE of -0.33%. Regarding short-term risk, EMR.AX is less volatile compared to ERM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check ERM.AX's competition here
EMR.AX vs GG8.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, GG8.AX has a market cap of 249.1M. Regarding current trading prices, EMR.AX is priced at A$5.66, while GG8.AX trades at A$0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas GG8.AX's P/E ratio is -34.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GG8.AX's ROE of -0.04%. Regarding short-term risk, EMR.AX is less volatile compared to GG8.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check GG8.AX's competition here
EMR.AX vs GCY.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, GCY.AX has a market cap of 245.6M. Regarding current trading prices, EMR.AX is priced at A$5.66, while GCY.AX trades at A$0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas GCY.AX's P/E ratio is -1.47. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GCY.AX's ROE of -0.40%. Regarding short-term risk, EMR.AX is more volatile compared to GCY.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check GCY.AX's competition here
EMR.AX vs TGM.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, TGM.AX has a market cap of 242.9M. Regarding current trading prices, EMR.AX is priced at A$5.66, while TGM.AX trades at A$0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas TGM.AX's P/E ratio is -21.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TGM.AX's ROE of -0.09%. Regarding short-term risk, EMR.AX is more volatile compared to TGM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check TGM.AX's competition here
EMR.AX vs FFX.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, FFX.AX has a market cap of 236.6M. Regarding current trading prices, EMR.AX is priced at A$5.66, while FFX.AX trades at A$0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas FFX.AX's P/E ratio is -4.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to FFX.AX's ROE of +1.76%. Regarding short-term risk, EMR.AX is less volatile compared to FFX.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check FFX.AX's competition here
EMR.AX vs TTM.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, TTM.AX has a market cap of 234.3M. Regarding current trading prices, EMR.AX is priced at A$5.66, while TTM.AX trades at A$0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas TTM.AX's P/E ratio is -40.75. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TTM.AX's ROE of -0.08%. Regarding short-term risk, EMR.AX is less volatile compared to TTM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check TTM.AX's competition here
EMR.AX vs HRN.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, HRN.AX has a market cap of 228M. Regarding current trading prices, EMR.AX is priced at A$5.66, while HRN.AX trades at A$1.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas HRN.AX's P/E ratio is -128.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to HRN.AX's ROE of -0.03%. Regarding short-term risk, EMR.AX is more volatile compared to HRN.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check HRN.AX's competition here
EMR.AX vs MGV.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, MGV.AX has a market cap of 227.6M. Regarding current trading prices, EMR.AX is priced at A$5.66, while MGV.AX trades at A$0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas MGV.AX's P/E ratio is -38.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to MGV.AX's ROE of -0.03%. Regarding short-term risk, EMR.AX is more volatile compared to MGV.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check MGV.AX's competition here
EMR.AX vs STN.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, STN.AX has a market cap of 216.5M. Regarding current trading prices, EMR.AX is priced at A$5.66, while STN.AX trades at A$0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas STN.AX's P/E ratio is -47.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to STN.AX's ROE of -0.05%. Regarding short-term risk, EMR.AX is less volatile compared to STN.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check STN.AX's competition here
EMR.AX vs TOR.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, TOR.AX has a market cap of 216.5M. Regarding current trading prices, EMR.AX is priced at A$5.66, while TOR.AX trades at A$0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas TOR.AX's P/E ratio is -21.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TOR.AX's ROE of -0.10%. Regarding short-term risk, EMR.AX is less volatile compared to TOR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check TOR.AX's competition here
EMR.AX vs BGD.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, BGD.AX has a market cap of 207.7M. Regarding current trading prices, EMR.AX is priced at A$5.66, while BGD.AX trades at A$0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas BGD.AX's P/E ratio is -14.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to BGD.AX's ROE of -0.88%. Regarding short-term risk, EMR.AX is less volatile compared to BGD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check BGD.AX's competition here
EMR.AX vs BTR.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, BTR.AX has a market cap of 193.5M. Regarding current trading prices, EMR.AX is priced at A$5.66, while BTR.AX trades at A$0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas BTR.AX's P/E ratio is -3.70. In terms of profitability, EMR.AX's ROE is +0.15%, compared to BTR.AX's ROE of -0.33%. Regarding short-term risk, EMR.AX is less volatile compared to BTR.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check BTR.AX's competition here
EMR.AX vs HAV.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, HAV.AX has a market cap of 189.3M. Regarding current trading prices, EMR.AX is priced at A$5.66, while HAV.AX trades at A$0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas HAV.AX's P/E ratio is -53.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to HAV.AX's ROE of -0.06%. Regarding short-term risk, EMR.AX is more volatile compared to HAV.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check HAV.AX's competition here
EMR.AX vs HRZ.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, HRZ.AX has a market cap of 180.3M. Regarding current trading prices, EMR.AX is priced at A$5.66, while HRZ.AX trades at A$0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas HRZ.AX's P/E ratio is -9.72. In terms of profitability, EMR.AX's ROE is +0.15%, compared to HRZ.AX's ROE of -0.03%. Regarding short-term risk, EMR.AX is less volatile compared to HRZ.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check HRZ.AX's competition here
EMR.AX vs POL.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, POL.AX has a market cap of 179.3M. Regarding current trading prices, EMR.AX is priced at A$5.66, while POL.AX trades at A$0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas POL.AX's P/E ratio is -2.22. In terms of profitability, EMR.AX's ROE is +0.15%, compared to POL.AX's ROE of -2.88%. Regarding short-term risk, EMR.AX is less volatile compared to POL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check POL.AX's competition here
EMR.AX vs AS1.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, AS1.AX has a market cap of 176.7M. Regarding current trading prices, EMR.AX is priced at A$5.66, while AS1.AX trades at A$0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas AS1.AX's P/E ratio is N/A. In terms of profitability, EMR.AX's ROE is +0.15%, compared to AS1.AX's ROE of -0.05%. Regarding short-term risk, EMR.AX is less volatile compared to AS1.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check AS1.AX's competition here
EMR.AX vs VTM.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, VTM.AX has a market cap of 170.5M. Regarding current trading prices, EMR.AX is priced at A$5.66, while VTM.AX trades at A$1.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas VTM.AX's P/E ratio is N/A. In terms of profitability, EMR.AX's ROE is +0.15%, compared to VTM.AX's ROE of -0.26%. Regarding short-term risk, EMR.AX is more volatile compared to VTM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check VTM.AX's competition here
EMR.AX vs KAU.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, KAU.AX has a market cap of 166.5M. Regarding current trading prices, EMR.AX is priced at A$5.66, while KAU.AX trades at A$0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas KAU.AX's P/E ratio is 27.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to KAU.AX's ROE of +0.03%. Regarding short-term risk, EMR.AX is less volatile compared to KAU.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check KAU.AX's competition here
EMR.AX vs GPR.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, GPR.AX has a market cap of 163.5M. Regarding current trading prices, EMR.AX is priced at A$5.66, while GPR.AX trades at A$0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas GPR.AX's P/E ratio is -5.10. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GPR.AX's ROE of -0.05%. Regarding short-term risk, EMR.AX is more volatile compared to GPR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check GPR.AX's competition here
EMR.AX vs LLO.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, LLO.AX has a market cap of 162.5M. Regarding current trading prices, EMR.AX is priced at A$5.66, while LLO.AX trades at A$0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas LLO.AX's P/E ratio is -10.33. In terms of profitability, EMR.AX's ROE is +0.15%, compared to LLO.AX's ROE of -0.01%. Regarding short-term risk, EMR.AX is less volatile compared to LLO.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check LLO.AX's competition here
EMR.AX vs VAL.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, VAL.AX has a market cap of 159.3M. Regarding current trading prices, EMR.AX is priced at A$5.66, while VAL.AX trades at A$0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas VAL.AX's P/E ratio is N/A. In terms of profitability, EMR.AX's ROE is +0.15%, compared to VAL.AX's ROE of +0.00%. Regarding short-term risk, EMR.AX is less volatile compared to VAL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check VAL.AX's competition here
EMR.AX vs BRB.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, BRB.AX has a market cap of 158.1M. Regarding current trading prices, EMR.AX is priced at A$5.66, while BRB.AX trades at A$0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas BRB.AX's P/E ratio is 3.65. In terms of profitability, EMR.AX's ROE is +0.15%, compared to BRB.AX's ROE of +0.05%. Regarding short-term risk, EMR.AX is less volatile compared to BRB.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check BRB.AX's competition here
EMR.AX vs DLI.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, DLI.AX has a market cap of 154.2M. Regarding current trading prices, EMR.AX is priced at A$5.66, while DLI.AX trades at A$0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas DLI.AX's P/E ratio is -21.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to DLI.AX's ROE of -0.01%. Regarding short-term risk, EMR.AX is less volatile compared to DLI.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check DLI.AX's competition here
EMR.AX vs CY5.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, CY5.AX has a market cap of 152.6M. Regarding current trading prices, EMR.AX is priced at A$5.66, while CY5.AX trades at A$0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas CY5.AX's P/E ratio is -12.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to CY5.AX's ROE of -0.06%. Regarding short-term risk, EMR.AX is less volatile compared to CY5.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check CY5.AX's competition here
EMR.AX vs GBM.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, GBM.AX has a market cap of 142.3M. Regarding current trading prices, EMR.AX is priced at A$5.66, while GBM.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas GBM.AX's P/E ratio is -2.90. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GBM.AX's ROE of +4.59%. Regarding short-term risk, EMR.AX is more volatile compared to GBM.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check GBM.AX's competition here
EMR.AX vs LSX.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, LSX.AX has a market cap of 131.1M. Regarding current trading prices, EMR.AX is priced at A$5.66, while LSX.AX trades at A$0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas LSX.AX's P/E ratio is 2.41. In terms of profitability, EMR.AX's ROE is +0.15%, compared to LSX.AX's ROE of +0.38%. Regarding short-term risk, EMR.AX is more volatile compared to LSX.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check LSX.AX's competition here
EMR.AX vs GBZ.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, GBZ.AX has a market cap of 131M. Regarding current trading prices, EMR.AX is priced at A$5.66, while GBZ.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas GBZ.AX's P/E ratio is -2.90. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GBZ.AX's ROE of -0.10%. Regarding short-term risk, EMR.AX is more volatile compared to GBZ.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check GBZ.AX's competition here
EMR.AX vs X64.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, X64.AX has a market cap of 129.9M. Regarding current trading prices, EMR.AX is priced at A$5.66, while X64.AX trades at A$0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas X64.AX's P/E ratio is 28.50. In terms of profitability, EMR.AX's ROE is +0.15%, compared to X64.AX's ROE of -0.00%. Regarding short-term risk, EMR.AX is more volatile compared to X64.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check X64.AX's competition here
EMR.AX vs LRL.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, LRL.AX has a market cap of 125.9M. Regarding current trading prices, EMR.AX is priced at A$5.66, while LRL.AX trades at A$0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas LRL.AX's P/E ratio is -11.25. In terms of profitability, EMR.AX's ROE is +0.15%, compared to LRL.AX's ROE of -0.56%. Regarding short-term risk, EMR.AX is more volatile compared to LRL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check LRL.AX's competition here
EMR.AX vs RND.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, RND.AX has a market cap of 123.4M. Regarding current trading prices, EMR.AX is priced at A$5.66, while RND.AX trades at A$2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas RND.AX's P/E ratio is 9.43. In terms of profitability, EMR.AX's ROE is +0.15%, compared to RND.AX's ROE of +0.14%. Regarding short-term risk, EMR.AX is more volatile compared to RND.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check RND.AX's competition here
EMR.AX vs FXG.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, FXG.AX has a market cap of 123M. Regarding current trading prices, EMR.AX is priced at A$5.66, while FXG.AX trades at A$0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas FXG.AX's P/E ratio is -25.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to FXG.AX's ROE of -0.11%. Regarding short-term risk, EMR.AX is less volatile compared to FXG.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check FXG.AX's competition here
EMR.AX vs TSO.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, TSO.AX has a market cap of 122.3M. Regarding current trading prices, EMR.AX is priced at A$5.66, while TSO.AX trades at A$0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas TSO.AX's P/E ratio is -22.62. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TSO.AX's ROE of -0.07%. Regarding short-term risk, EMR.AX is more volatile compared to TSO.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check TSO.AX's competition here
EMR.AX vs TUL.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, TUL.AX has a market cap of 116.6M. Regarding current trading prices, EMR.AX is priced at A$5.66, while TUL.AX trades at A$0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas TUL.AX's P/E ratio is -2.88. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TUL.AX's ROE of N/A. Regarding short-term risk, EMR.AX is more volatile compared to TUL.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check TUL.AX's competition here
EMR.AX vs AQI.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, AQI.AX has a market cap of 116.4M. Regarding current trading prices, EMR.AX is priced at A$5.66, while AQI.AX trades at A$1.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas AQI.AX's P/E ratio is -20.37. In terms of profitability, EMR.AX's ROE is +0.15%, compared to AQI.AX's ROE of -0.45%. Regarding short-term risk, EMR.AX is less volatile compared to AQI.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check AQI.AX's competition here
EMR.AX vs MMC.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, MMC.AX has a market cap of 115.1M. Regarding current trading prices, EMR.AX is priced at A$5.66, while MMC.AX trades at A$0.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas MMC.AX's P/E ratio is -11.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to MMC.AX's ROE of -0.39%. Regarding short-term risk, EMR.AX is more volatile compared to MMC.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check MMC.AX's competition here
EMR.AX vs TAM.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, TAM.AX has a market cap of 108.1M. Regarding current trading prices, EMR.AX is priced at A$5.66, while TAM.AX trades at A$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas TAM.AX's P/E ratio is -9.20. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TAM.AX's ROE of -0.13%. Regarding short-term risk, EMR.AX is less volatile compared to TAM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check TAM.AX's competition here
EMR.AX vs SKY.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, SKY.AX has a market cap of 105.8M. Regarding current trading prices, EMR.AX is priced at A$5.66, while SKY.AX trades at A$0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas SKY.AX's P/E ratio is -6.75. In terms of profitability, EMR.AX's ROE is +0.15%, compared to SKY.AX's ROE of -0.20%. Regarding short-term risk, EMR.AX is more volatile compared to SKY.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check SKY.AX's competition here
EMR.AX vs PTN.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, PTN.AX has a market cap of 97.6M. Regarding current trading prices, EMR.AX is priced at A$5.66, while PTN.AX trades at A$0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas PTN.AX's P/E ratio is -6.60. In terms of profitability, EMR.AX's ROE is +0.15%, compared to PTN.AX's ROE of -0.09%. Regarding short-term risk, EMR.AX is more volatile compared to PTN.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check PTN.AX's competition here
EMR.AX vs KGD.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, KGD.AX has a market cap of 96M. Regarding current trading prices, EMR.AX is priced at A$5.66, while KGD.AX trades at A$0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas KGD.AX's P/E ratio is -8.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to KGD.AX's ROE of -1.31%. Regarding short-term risk, EMR.AX is less volatile compared to KGD.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check KGD.AX's competition here
EMR.AX vs CAI.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, CAI.AX has a market cap of 93.7M. Regarding current trading prices, EMR.AX is priced at A$5.66, while CAI.AX trades at A$0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas CAI.AX's P/E ratio is -3.83. In terms of profitability, EMR.AX's ROE is +0.15%, compared to CAI.AX's ROE of -0.05%. Regarding short-term risk, EMR.AX is less volatile compared to CAI.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check CAI.AX's competition here
EMR.AX vs GHM.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, GHM.AX has a market cap of 88.4M. Regarding current trading prices, EMR.AX is priced at A$5.66, while GHM.AX trades at A$0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas GHM.AX's P/E ratio is -2.97. In terms of profitability, EMR.AX's ROE is +0.15%, compared to GHM.AX's ROE of -0.17%. Regarding short-term risk, EMR.AX is less volatile compared to GHM.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check GHM.AX's competition here
EMR.AX vs FAL.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, FAL.AX has a market cap of 86.3M. Regarding current trading prices, EMR.AX is priced at A$5.66, while FAL.AX trades at A$0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas FAL.AX's P/E ratio is -16.17. In terms of profitability, EMR.AX's ROE is +0.15%, compared to FAL.AX's ROE of -0.56%. Regarding short-term risk, EMR.AX is less volatile compared to FAL.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check FAL.AX's competition here
EMR.AX vs TRY.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, TRY.AX has a market cap of 78.9M. Regarding current trading prices, EMR.AX is priced at A$5.66, while TRY.AX trades at A$0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas TRY.AX's P/E ratio is -0.74. In terms of profitability, EMR.AX's ROE is +0.15%, compared to TRY.AX's ROE of +4.97%. Regarding short-term risk, EMR.AX is less volatile compared to TRY.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check TRY.AX's competition here
EMR.AX vs KSN.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, KSN.AX has a market cap of 76.6M. Regarding current trading prices, EMR.AX is priced at A$5.66, while KSN.AX trades at A$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas KSN.AX's P/E ratio is 2.28. In terms of profitability, EMR.AX's ROE is +0.15%, compared to KSN.AX's ROE of +0.30%. Regarding short-term risk, EMR.AX is more volatile compared to KSN.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check KSN.AX's competition here
EMR.AX vs WMC.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, WMC.AX has a market cap of 72.7M. Regarding current trading prices, EMR.AX is priced at A$5.66, while WMC.AX trades at A$0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas WMC.AX's P/E ratio is -6.83. In terms of profitability, EMR.AX's ROE is +0.15%, compared to WMC.AX's ROE of +0.15%. Regarding short-term risk, EMR.AX is less volatile compared to WMC.AX. This indicates potentially lower risk in terms of short-term price fluctuations for EMR.AX.Check WMC.AX's competition here
EMR.AX vs MAT.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, MAT.AX has a market cap of 72M. Regarding current trading prices, EMR.AX is priced at A$5.66, while MAT.AX trades at A$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas MAT.AX's P/E ratio is -3.07. In terms of profitability, EMR.AX's ROE is +0.15%, compared to MAT.AX's ROE of -1.42%. Regarding short-term risk, EMR.AX is more volatile compared to MAT.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check MAT.AX's competition here
EMR.AX vs MDX.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, MDX.AX has a market cap of 70.9M. Regarding current trading prices, EMR.AX is priced at A$5.66, while MDX.AX trades at A$0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas MDX.AX's P/E ratio is 3.00. In terms of profitability, EMR.AX's ROE is +0.15%, compared to MDX.AX's ROE of -0.14%. Regarding short-term risk, EMR.AX is more volatile compared to MDX.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check MDX.AX's competition here
EMR.AX vs AME.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, AME.AX has a market cap of 69.5M. Regarding current trading prices, EMR.AX is priced at A$5.66, while AME.AX trades at A$0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas AME.AX's P/E ratio is -9.40. In terms of profitability, EMR.AX's ROE is +0.15%, compared to AME.AX's ROE of -0.06%. Regarding short-term risk, EMR.AX is more volatile compared to AME.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check AME.AX's competition here
EMR.AX vs KIN.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, KIN.AX has a market cap of 67.2M. Regarding current trading prices, EMR.AX is priced at A$5.66, while KIN.AX trades at A$0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas KIN.AX's P/E ratio is -5.70. In terms of profitability, EMR.AX's ROE is +0.15%, compared to KIN.AX's ROE of -0.62%. Regarding short-term risk, EMR.AX is more volatile compared to KIN.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check KIN.AX's competition here
EMR.AX vs IXR.AX Comparison April 2026
EMR.AX plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EMR.AX stands at 3.7B. In comparison, IXR.AX has a market cap of 66.7M. Regarding current trading prices, EMR.AX is priced at A$5.66, while IXR.AX trades at A$0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EMR.AX currently has a P/E ratio of 37.73, whereas IXR.AX's P/E ratio is -5.90. In terms of profitability, EMR.AX's ROE is +0.15%, compared to IXR.AX's ROE of -0.31%. Regarding short-term risk, EMR.AX is more volatile compared to IXR.AX. This indicates potentially higher risk in terms of short-term price fluctuations for EMR.AX.Check IXR.AX's competition here